SLC6A3 and Parkinson disease: Contrary to guidelines suggesting symmetric DAT reduction in DLB and asymmetric reduction in PD, 5 of 10 DLB patients with reduced DAT uptake had asymmetric reduction—consistent with Lee YG’s report [44].